UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating Brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease

Movement disorders, 2020-03, Vol.35 (3), p.457-467

2020

Volltextzugriff (PDF)

Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin‐Related Parkinson's Disease

Movement disorders, 2024-04, Vol.39 (4), p.715-722

2024

Volltextzugriff (PDF)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study

Journal of Parkinson's disease, 2023-01, Vol.13 (5), p.811-818

2023

Volltextzugriff (PDF)

Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI Study

Journal of Parkinson's disease, 2021-01, Vol.11 (2), p.633-640

2021

Volltextzugriff (PDF)

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson’s Disease: Data from the PPMI Study

Journal of Parkinson's disease, 2020, Vol.10 (2), p.481-487

2020

Volltextzugriff (PDF)

Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson’s disease patients

Neuroscience letters, 2019-06, Vol.704, p.112-115

2019

Volltextzugriff (PDF)

A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease

Movement disorders, 2021-07, Vol.36 (7), p.1624-1633

2021

Volltextzugriff (PDF)

Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease

Neuroscience letters, 2018-04, Vol.672, p.145-149

2018

Volltextzugriff (PDF)

Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review

Complementary therapies in clinical practice, 2020-05, Vol.39, p.101154-101154, Article 101154

2020

Volltextzugriff (PDF)

The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease

Parkinsonism & related disorders, 2019-10, Vol.67, p.105-112

2019

Volltextzugriff (PDF)

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study

Parkinsonism & related disorders, 2021-03, Vol.84, p.1-4

2021

Volltextzugriff (PDF)

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients

Annals of clinical and translational neurology, 2020-09, Vol.7 (9), p.1594-1607

2020

Volltextzugriff (PDF)

Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It?

Medicina (Kaunas, Lithuania), 2023-11, Vol.59 (11), p.1942

2023

Volltextzugriff (PDF)

DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study

Parkinsonism & related disorders, 2020-08, Vol.77, p.36-42

2020

Volltextzugriff (PDF)

Ambiental Factors in Parkinson's Disease Progression: A Systematic Review

Medicina (Kaunas, Lithuania), 2023-02, Vol.59 (2), p.294

2023

Volltextzugriff (PDF)

CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease From Atypical Parkinsonian Syndromes: Meta-analysis

Neurology. Clinical practice, 2021-12, Vol.11 (6), p.e867-e875

2021

Volltextzugriff (PDF)

Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review

Neurology international, 2024-07, Vol.16 (4), p.833-844

2024

Volltextzugriff (PDF)

REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers

Sleep (New York, N.Y.), 2021-05, Vol.44 (5), p.1

2021

Volltextzugriff (PDF)

Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease

Journal of the neurological sciences, 2022-11, Vol.442, p.120405-120405, Article 120405

2022

Volltextzugriff (PDF)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

Journal of neurology, 2023-12, Vol.270 (12), p.5773-5783

2023

Volltextzugriff (PDF)

The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review

Genes, 2023-11, Vol.14 (11), p.2097

2023

Volltextzugriff (PDF)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors

Annals of neurology, 2022-08, Vol.92 (2), p.270-278

2022

Volltextzugriff (PDF)

Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study

Parkinsonism & related disorders, 2022-05, Vol.98, p.72-74

2022

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Circulating Brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease

Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin‐Related Parkinson's Disease

Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report

Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI Study

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson’s Disease: Data from the PPMI Study

Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson’s disease patients

A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease

Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease

Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review

The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients

Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It?

DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study

Ambiental Factors in Parkinson's Disease Progression: A Systematic Review

CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease From Atypical Parkinsonian Syndromes: Meta-analysis

Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review

REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers

Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors

Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study

Suchergebnisse filtern